Cite
HARVARD Citation
Klughammer, B. et al. (2016). Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations. Journal of thoracic oncology. 11 (4), p. . [Online].